1Alaupovic P,Mack WJ,Knight-Gibson C,et al.The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.Arterioscler Thromb Vasc Biol,1997
2Samuelsson O,Mulec H,Knight-Gibson C,et al.Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.Nephrol Dial Transplant,1997,12:1908-1915.
3Shearer GC,Stevenson FT,Atkinson DN,et al.Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.Kidney Int,2001,59:179-189.
4de Sain-van der Velden MG,Kaysen GA,Barrett HA,et al.Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.Kidney Int,1998,53:994-1001.
5Shearer GC,Kaysen GA.Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.Am J Kidney Dis,2001,37(1 Suppl 2):S119-S122.
6Sato T,Liang K,Vaziri ND.Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.Kidney Int,2002,61:157-162.
7Joven J,Villabona C,Vilella E,et al.Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.N Engl J Med,1990,323:579-584.
8Kaysen GA.Nephrotic hyperlipidemia:primary abnormalities in both lipoprotein catabolism and synthesis.Miner Electrolyte Metab,1992,18:212-216.
9Doucet C,Mooser V,Gonbert S,et al.Lipoprotein(a) in the nephrotic syndrome:molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine.J Am Soc Nephrol,2000,11:507-513.
10Vaziri ND,Sato T,Liang K.Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.Kidney Int,2003,63:1756-1763.
8Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：349
9Demarchi DA,Salzano FM,Altuna ME,et al.APOE polymorphism distribution among Native Americans and related populations[J].Ann Hum Bio1,2005,32(3):351-365.
10Uterman G,Kindermann L.Apolipoprotein E phenotypes and hyperlipidemia[J].Hum Genet,1984,65 (3):232.
